Latest news with #JBM Healthcare
Yahoo
2 days ago
- Business
- Yahoo
Asian Market Highlights: Penny Stocks To Watch In August 2025
As global markets navigate a landscape marked by shifting trade policies and monetary adjustments, the Asian market continues to capture attention with its diverse economic activities and robust stock performances. Amidst this backdrop, penny stocks—though an older term—remain a focal point for investors seeking potential growth in smaller or newer companies. By identifying those with strong financial health, investors can uncover opportunities that balance risk with promising returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.30 THB4.25B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$2.86 HK$2.33B ★★★★★★ Lever Style (SEHK:1346) HK$1.48 HK$915.41M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.52 HK$2.1B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.68 SGD648.3M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.88 SGD11.33B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.95 THB1.4B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.82 THB9.74B ★★★★★★ BRC Asia (SGX:BEC) SGD3.55 SGD973.94M ★★★★★★ Click here to see the full list of 977 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. K. Wah International Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: K. Wah International Holdings Limited is an investment holding company involved in property development and investment in Hong Kong and Mainland China, with a market capitalization of approximately HK$7.79 billion. Operations: The company's revenue is primarily derived from property development in Mainland China (HK$5.91 billion) and Hong Kong (HK$540.49 million), along with property investment generating HK$642.97 million. Market Cap: HK$7.79B K. Wah International Holdings, with a market capitalization of HK$7.79 billion, derives substantial revenue from property development in Mainland China and Hong Kong. It has managed to reduce its debt-to-equity ratio over the past five years, maintaining a satisfactory net debt level relative to equity. The company's short-term assets significantly exceed both its short- and long-term liabilities, reflecting strong liquidity. However, recent earnings have declined sharply by 58.2%, with forecasts indicating further declines over the next three years. Despite trading below estimated fair value, its return on equity remains low at 0.9%, and dividend stability is uncertain due to an unstable track record. Click here and access our complete financial health analysis report to understand the dynamics of K. Wah International Holdings. Learn about K. Wah International Holdings' future growth trajectory here. China Shanshui Cement Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Shanshui Cement Group Limited is an investment holding company that manufactures and sells cement, clinker, concrete, and related products and services in the People's Republic of China, with a market cap of HK$3.83 billion. Operations: The company generates CN¥13.50 billion in revenue from its operations in manufacturing and trading cement, clinker, and concrete. Market Cap: HK$3.83B China Shanshui Cement Group has seen a volatile share price recently, reflecting broader challenges in the sector. Despite becoming profitable last year, its earnings have been impacted by large one-off items and declining sales, with recent half-year revenue at CN¥5.55 billion compared to CN¥6.57 billion previously. The company reported a net loss of CN¥250 million for the same period but has improved from a larger loss last year. Its debt management is prudent with a satisfactory net debt to equity ratio of 13.2%, though short-term liabilities exceed assets, posing potential liquidity concerns amidst ongoing legal issues and governance changes. Click here to discover the nuances of China Shanshui Cement Group with our detailed analytical financial health report. Explore historical data to track China Shanshui Cement Group's performance over time in our past results report. Fuan Pharmaceutical (Group) Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Fuan Pharmaceutical (Group) Co., Ltd. is engaged in the research, development, production, and sale of chemical drugs in China with a market cap of CN¥5.85 billion. Operations: The company generates CN¥2.05 billion in revenue from its pharmaceutical industry segment. Market Cap: CN¥5.85B Fuan Pharmaceutical (Group) Co., Ltd. offers a stable investment profile within the penny stock segment, with its CN¥2.05 billion revenue from pharmaceuticals and a market cap of CN¥5.85 billion. The company boasts seasoned management and board teams, with average tenures of 14.3 and 3.7 years respectively, supporting strategic continuity. Short-term assets comfortably cover both short- and long-term liabilities, while operating cash flow adequately covers debt obligations at 20%. Despite negative earnings growth last year, profit margins improved to 11% from 9.7%, indicating operational resilience amid challenges in the broader pharmaceutical industry landscape. Navigate through the intricacies of Fuan Pharmaceutical (Group) with our comprehensive balance sheet health report here. Gain insights into Fuan Pharmaceutical (Group)'s past trends and performance with our report on the company's historical track record. Seize The Opportunity Click through to start exploring the rest of the 974 Asian Penny Stocks now. Interested In Other Possibilities? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:173 SEHK:691 and SZSE:300194. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
2 days ago
- Business
- Yahoo
Asian Market Highlights: Penny Stocks To Watch In August 2025
As global markets navigate a landscape marked by shifting trade policies and monetary adjustments, the Asian market continues to capture attention with its diverse economic activities and robust stock performances. Amidst this backdrop, penny stocks—though an older term—remain a focal point for investors seeking potential growth in smaller or newer companies. By identifying those with strong financial health, investors can uncover opportunities that balance risk with promising returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.30 THB4.25B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$2.86 HK$2.33B ★★★★★★ Lever Style (SEHK:1346) HK$1.48 HK$915.41M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.52 HK$2.1B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.68 SGD648.3M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.88 SGD11.33B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.95 THB1.4B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.82 THB9.74B ★★★★★★ BRC Asia (SGX:BEC) SGD3.55 SGD973.94M ★★★★★★ Click here to see the full list of 977 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. K. Wah International Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: K. Wah International Holdings Limited is an investment holding company involved in property development and investment in Hong Kong and Mainland China, with a market capitalization of approximately HK$7.79 billion. Operations: The company's revenue is primarily derived from property development in Mainland China (HK$5.91 billion) and Hong Kong (HK$540.49 million), along with property investment generating HK$642.97 million. Market Cap: HK$7.79B K. Wah International Holdings, with a market capitalization of HK$7.79 billion, derives substantial revenue from property development in Mainland China and Hong Kong. It has managed to reduce its debt-to-equity ratio over the past five years, maintaining a satisfactory net debt level relative to equity. The company's short-term assets significantly exceed both its short- and long-term liabilities, reflecting strong liquidity. However, recent earnings have declined sharply by 58.2%, with forecasts indicating further declines over the next three years. Despite trading below estimated fair value, its return on equity remains low at 0.9%, and dividend stability is uncertain due to an unstable track record. Click here and access our complete financial health analysis report to understand the dynamics of K. Wah International Holdings. Learn about K. Wah International Holdings' future growth trajectory here. China Shanshui Cement Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Shanshui Cement Group Limited is an investment holding company that manufactures and sells cement, clinker, concrete, and related products and services in the People's Republic of China, with a market cap of HK$3.83 billion. Operations: The company generates CN¥13.50 billion in revenue from its operations in manufacturing and trading cement, clinker, and concrete. Market Cap: HK$3.83B China Shanshui Cement Group has seen a volatile share price recently, reflecting broader challenges in the sector. Despite becoming profitable last year, its earnings have been impacted by large one-off items and declining sales, with recent half-year revenue at CN¥5.55 billion compared to CN¥6.57 billion previously. The company reported a net loss of CN¥250 million for the same period but has improved from a larger loss last year. Its debt management is prudent with a satisfactory net debt to equity ratio of 13.2%, though short-term liabilities exceed assets, posing potential liquidity concerns amidst ongoing legal issues and governance changes. Click here to discover the nuances of China Shanshui Cement Group with our detailed analytical financial health report. Explore historical data to track China Shanshui Cement Group's performance over time in our past results report. Fuan Pharmaceutical (Group) Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Fuan Pharmaceutical (Group) Co., Ltd. is engaged in the research, development, production, and sale of chemical drugs in China with a market cap of CN¥5.85 billion. Operations: The company generates CN¥2.05 billion in revenue from its pharmaceutical industry segment. Market Cap: CN¥5.85B Fuan Pharmaceutical (Group) Co., Ltd. offers a stable investment profile within the penny stock segment, with its CN¥2.05 billion revenue from pharmaceuticals and a market cap of CN¥5.85 billion. The company boasts seasoned management and board teams, with average tenures of 14.3 and 3.7 years respectively, supporting strategic continuity. Short-term assets comfortably cover both short- and long-term liabilities, while operating cash flow adequately covers debt obligations at 20%. Despite negative earnings growth last year, profit margins improved to 11% from 9.7%, indicating operational resilience amid challenges in the broader pharmaceutical industry landscape. Navigate through the intricacies of Fuan Pharmaceutical (Group) with our comprehensive balance sheet health report here. Gain insights into Fuan Pharmaceutical (Group)'s past trends and performance with our report on the company's historical track record. Seize The Opportunity Click through to start exploring the rest of the 974 Asian Penny Stocks now. Interested In Other Possibilities? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:173 SEHK:691 and SZSE:300194. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Luzhou Bank Leads The Pack Of 3 Asian Penny Stocks To Consider
As global markets navigate a landscape marked by interest rate adjustments and trade policy developments, investors are increasingly looking towards Asia for emerging opportunities. Penny stocks, though often associated with speculative trading, still hold potential when backed by robust financials and strategic positioning. In this article, we explore three Asian penny stocks that demonstrate notable financial strength and growth potential amidst the evolving economic backdrop. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.30 THB4.25B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$2.86 HK$2.33B ★★★★★★ Lever Style (SEHK:1346) HK$1.48 HK$915.41M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.52 HK$2.1B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.68 SGD648.3M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.88 SGD11.33B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.95 THB1.4B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.82 THB9.74B ★★★★★★ BRC Asia (SGX:BEC) SGD3.55 SGD973.94M ★★★★★★ Click here to see the full list of 977 stocks from our Asian Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Luzhou Bank Simply Wall St Financial Health Rating: ★★★★★★ Overview: Luzhou Bank Co., Ltd. offers corporate and retail banking, financial market, and other services in the People's Republic of China, with a market cap of HK$6.50 billion. Operations: Luzhou Bank Co., Ltd. has not reported specific revenue segments. Market Cap: HK$6.5B Luzhou Bank, with a market cap of HK$6.50 billion, demonstrates financial stability through its primarily low-risk funding sources, as 87% of liabilities are customer deposits. The bank has experienced earnings growth of 12.6% over the past year, outpacing industry averages and maintaining a moderate assets-to-equity ratio of 15.6x. Despite a slightly lower net profit margin compared to last year, Luzhou Bank's bad loan allowance is robust at 435%, and it has an appropriate loans-to-assets ratio of 58%. Recent AGM decisions include dividend affirmations and amendments to the Articles of Association. Jump into the full analysis health report here for a deeper understanding of Luzhou Bank. Evaluate Luzhou Bank's historical performance by accessing our past performance report. Xinjiang Xinxin Mining Industry Simply Wall St Financial Health Rating: ★★★★★★ Overview: Xinjiang Xinxin Mining Industry Co., Ltd. operates in the mining, ore processing, smelting, refining, and sale of nickel, copper, and other nonferrous metals with a market cap of HK$2.59 billion. Operations: The company generates CN¥2.28 billion in revenue from its metals and mining miscellaneous segment. Market Cap: HK$2.59B Xinjiang Xinxin Mining Industry, with a market cap of HK$2.59 billion, has shown stable weekly volatility over the past year and improved its debt-to-equity ratio from 49% to 13.7% over five years. Despite a substantial decrease in net profit due to lower nickel prices and increased production costs, the company maintains well-covered interest payments and satisfactory net debt levels. Recent board changes include appointing Ms. Zhang Li as an employee representative director, while the company continues to distribute dividends with RMB 0.05 per share approved for last year's performance amidst ongoing amendments to its Articles of Association. Unlock comprehensive insights into our analysis of Xinjiang Xinxin Mining Industry stock in this financial health report. Assess Xinjiang Xinxin Mining Industry's previous results with our detailed historical performance reports. Value Partners Group Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Value Partners Group Limited is a publicly owned investment manager with a market cap of HK$4.35 billion. Operations: Value Partners Group Limited has not reported any specific revenue segments. Market Cap: HK$4.35B Value Partners Group Limited, with a market cap of HK$4.35 billion, has demonstrated significant earnings growth of 341.6% over the past year, largely driven by substantial net fair value gains on investments. Despite this impressive short-term performance and a low price-to-earnings ratio of 17.7x compared to industry averages, the company faces challenges such as low return on equity at 6.4% and negative operating cash flow impacting debt coverage. The board and management team are relatively inexperienced with an average tenure of one year, highlighting potential governance risks amidst their strategic decisions moving forward. Click here and access our complete financial health analysis report to understand the dynamics of Value Partners Group. Gain insights into Value Partners Group's future direction by reviewing our growth report. Key Takeaways Click this link to deep-dive into the 977 companies within our Asian Penny Stocks screener. Contemplating Other Strategies? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1983 SEHK:3833 and SEHK:806. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
3 days ago
- Business
- Yahoo
Asian Penny Stocks To Watch With Market Caps Over US$100M
As global markets continue to navigate a complex landscape, Asian indices have shown resilience with notable performances in regions like Japan and China. Amid these broader market movements, penny stocks—often representing smaller or newer companies—remain a compelling area of interest for investors seeking growth opportunities at lower price points. Despite their vintage name, penny stocks can still offer surprising value when backed by strong financials and solid fundamentals, making them worthy of attention for those looking to uncover hidden gems in the market. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.36 THB4.31B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$2.87 HK$2.34B ★★★★★★ Lever Style (SEHK:1346) HK$1.49 HK$921.6M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.52 HK$2.1B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.55 SGD222.91M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.89 SGD11.37B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.95 THB1.4B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.88 THB9.86B ★★★★★★ BRC Asia (SGX:BEC) SGD3.57 SGD979.43M ★★★★★★ Click here to see the full list of 974 stocks from our Asian Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Sunshine Insurance Group Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sunshine Insurance Group Company Limited offers a range of insurance products and related services in the People's Republic of China, with a market capitalization of approximately HK$44.97 billion. Operations: The company's revenue segments include Life Insurance generating CN¥25.03 billion, Property and Casualty Insurance through Sunshine P&C contributing CN¥50.22 billion, and Property and Casualty Insurance via Sunshine Surety adding CN¥52 million. Market Cap: HK$44.97B Sunshine Insurance Group, with a market capitalization of approximately HK$44.97 billion, demonstrates financial stability through its diverse revenue streams in life and property insurance. Despite having short-term assets of CN¥160.7 billion that do not cover long-term liabilities of CN¥490.1 billion, the company maintains strong cash flow coverage for its debt and interest payments. Recent board changes aim to strengthen governance with experienced directors joining the team. The approved dividend increase reflects confidence in future profitability, while earnings growth forecasts suggest moderate expansion potential amidst industry challenges. Shareholders have not faced dilution recently, supporting investor sentiment positively. Jump into the full analysis health report here for a deeper understanding of Sunshine Insurance Group. Learn about Sunshine Insurance Group's future growth trajectory here. China Brilliant Global Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Brilliant Global Limited is an investment holding company involved in the research and development, design, wholesale, and retail of gold and jewelry in Hong Kong and the People's Republic of China, with a market cap of HK$581.44 million. Operations: The company's revenue is primarily generated from its Gold and Jewellery Business at HK$60.97 million, followed by the Trading Business at HK$25.29 million, Property Management Services Business at HK$20.35 million, and Lending Business at HK$0.77 million. Market Cap: HK$581.44M China Brilliant Global Limited, with a market cap of HK$581.44 million, has transitioned to profitability, reporting net income of HK$10.07 million for the year ended March 31, 2025. This turnaround is supported by strong performance in its property management business and reversal of previous impairment losses. The company's financial position is robust, with more cash than total debt and short-term assets exceeding liabilities by a significant margin. Despite high share price volatility and low return on equity at 3.1%, stable earnings quality and experienced management provide potential stability for investors seeking opportunities in penny stocks. Unlock comprehensive insights into our analysis of China Brilliant Global stock in this financial health report. Gain insights into China Brilliant Global's historical outcomes by reviewing our past performance report. International Cement Group Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: International Cement Group Ltd. operates in the production, sale, and distribution of cement and gypsum plasterboards across several countries including Singapore, Malaysia, Afghanistan, Tajikistan, and Kazakhstan with a market cap of SGD183.51 million. Operations: No specific revenue segments are reported for International Cement Group Ltd., which is involved in producing and distributing cement and gypsum plasterboards across various countries. Market Cap: SGD183.51M International Cement Group Ltd. has shown significant improvement in its financial performance, with earnings growing by 153.5% over the past year, surpassing industry averages. The company's recent half-year results reveal sales of SGD165.12 million and net income of SGD14.88 million, marking a substantial increase from the previous year. Its debt is well-covered by operating cash flow at 196.6%, and short-term assets exceed short-term liabilities, although they fall short in covering long-term liabilities of SGD225.3 million. Despite increased volatility and low return on equity at 7%, experienced management offers some stability amidst these challenges for penny stock investors. Click here and access our complete financial health analysis report to understand the dynamics of International Cement Group. Examine International Cement Group's past performance report to understand how it has performed in prior years. Taking Advantage Explore the 974 names from our Asian Penny Stocks screener here. Looking For Alternative Opportunities? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:6963 SEHK:8026 and SGX:KUO. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
3 Asian Penny Stocks With Market Caps Under US$9B
Amidst a backdrop of global economic shifts and policy changes, Asian markets have demonstrated resilience, with notable performances in key indices. Penny stocks, while often associated with speculative trading, can still offer substantial opportunities when supported by strong financial foundations. In this context, we explore three promising Asian penny stocks that combine growth potential with solid fundamentals, presenting intriguing prospects for investors seeking value in smaller companies. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.34 THB4.29B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$3.07 HK$2.5B ★★★★★★ Lever Style (SEHK:1346) HK$1.45 HK$914.88M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.48 HK$2.07B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.55 SGD222.91M ★★★★★☆ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.87 SGD11.3B ★★★★★☆ Ekarat Engineering (SET:AKR) THB1.02 THB1.5B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.86 THB9.82B ★★★★★★ BRC Asia (SGX:BEC) SGD3.59 SGD984.92M ★★★★★★ Click here to see the full list of 978 stocks from our Asian Penny Stocks screener. Let's explore several standout options from the results in the screener. Guangzhou Automobile Group Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Guangzhou Automobile Group Co., Ltd. operates in the research, development, manufacture, and sale of vehicles and motorcycles, along with parts and components in Mainland China and internationally, with a market cap of HK$69.61 billion. Operations: Guangzhou Automobile Group Co., Ltd. has not reported specific revenue segments. Market Cap: HK$69.61B Guangzhou Automobile Group faces challenges as recent sales and production figures indicate year-on-year declines of 8.22% and 10.05%, respectively, for June 2025. Despite this, the company maintains a strong financial position with short-term assets exceeding both short- and long-term liabilities, and more cash than total debt. The strategic Brazil expansion underlines its commitment to international growth, though profitability remains an issue with rising losses over five years at an annual rate of 19.3%. Management's experience is a positive factor, while the stock trades at good value compared to peers despite being removed from a key index recently. Unlock comprehensive insights into our analysis of Guangzhou Automobile Group stock in this financial health report. Gain insights into Guangzhou Automobile Group's outlook and expected performance with our report on the company's earnings estimates. Guoquan Food (Shanghai) Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Guoquan Food (Shanghai) Co., Ltd. operates as a home meal products company in Mainland China and has a market cap of HK$9.93 billion. Operations: The company generates revenue from its Retail - Grocery Stores segment, amounting to CN¥7.04 billion. Market Cap: HK$9.93B Guoquan Food (Shanghai) Co., Ltd. shows robust financial health with short-term assets of CN¥3 billion surpassing both short- and long-term liabilities. Recent earnings reveal a significant improvement, with net income for the half-year reaching CN¥183.34 million, up from CN¥85.98 million the previous year, reflecting enhanced operating efficiency and strategic expansion of its retail network. The company is trading below estimated fair value by 21%, offering potential investment appeal despite a low return on equity at 11%. The board's average tenure suggests inexperience, but management remains seasoned with over five years of expertise. Click here and access our complete financial health analysis report to understand the dynamics of Guoquan Food (Shanghai). Assess Guoquan Food (Shanghai)'s future earnings estimates with our detailed growth reports. Jiaze Renewables Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Jiaze Renewables Corporation Limited, with a market cap of CN¥94.94 billion, focuses on the development, construction, sale, operation, and maintenance of new energy power stations in China through its subsidiaries. Operations: The company's revenue primarily comes from its operations in China, totaling CN¥2.49 billion. Market Cap: CN¥9.49B Jiaze Renewables faces challenges with negative earnings growth over the past year, contrasting its 18.7% annual growth over five years. Despite a high net debt to equity ratio of 70.7%, interest payments are well covered by EBIT, indicating manageable debt levels. The company's short-term assets exceed short-term liabilities but fall short against long-term obligations, highlighting potential liquidity concerns. Trading at 33.4% below estimated fair value suggests it may offer good relative value compared to peers, though its return on equity remains low at 9.8%. Recent shareholder meetings and earnings calls indicate active corporate governance engagement. Navigate through the intricacies of Jiaze Renewables with our comprehensive balance sheet health report here. Learn about Jiaze Renewables' future growth trajectory here. Seize The Opportunity Discover the full array of 978 Asian Penny Stocks right here. Interested In Other Possibilities? AI is about to change healthcare. These 24 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2238 SEHK:2517 and SHSE:601619. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
